西藏药业股价下跌1.62% 创新药布局引关注

金融界2025-08-23

西藏药业股价报46.04元，较前一交易日下跌1.62%。盘中最高触及46.70元，最低下探至45.69元，成交量为98714手，成交金额达4.54亿元。西藏药业属于生物制品行业，公司主要从事中成药、藏成药及化学药品的研发、生产和销售。2025年半年报显示，公司投资3亿元参股江苏晨泰医药，持股比例为13.04%。晨泰医药研发的佐利替尼是全球首款针对伴中枢神经系统转移的晚期非小细胞肺癌开展注册临床试验...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2561540060?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-23 04:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2561540060","market":"hk","top_or_hot":-1,"title":"西藏药业股价下跌1.62% 创新药布局引关注","media":"金融界","content":"<div>\n<p>西藏药业股价报46.04元，较前一交易日下跌1.62%。盘中最高触及46.70元，最低下探至45.69元，成交量为98714手，成交金额达4.54亿元。西藏药业属于生物制品行业，公司主要从事中成药、藏成药及化学药品的研发、生产和销售。2025年半年报显示，公司投资3亿元参股江苏晨泰医药，持股比例为13.04%。晨泰医药研发的佐利替尼是全球首款针对伴中枢神经系统转移的晚期非小细胞肺癌开展注册临床试验...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/08/23040352636635.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>西藏药业股价下跌1.62% 创新药布局引关注</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n西藏药业股价下跌1.62% 创新药布局引关注\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-23 04:03 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.jrj.com.cn/2025/08/23040352636635.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>西藏药业股价报46.04元，较前一交易日下跌1.62%。盘中最高触及46.70元，最低下探至45.69元，成交量为98714手，成交金额达4.54亿元。西藏药业属于生物制品行业，公司主要从事中成药、藏成药及化学药品的研发、生产和销售。2025年半年报显示，公司投资3亿元参股江苏晨泰医药，持股比例为13.04%。晨泰医药研发的佐利替尼是全球首款针对伴中枢神经系统转移的晚期非小细胞肺癌开展注册临床试验...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/08/23040352636635.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://finance.jrj.com.cn/2025/08/23040352636635.shtml","article_id":"2561540060","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561540060","pubTimestamp":1755892985,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"西藏药业股价报46.04元，较前一交易日下跌1.62%。盘中最高触及46.70元，最低下探至45.69元，成交量为98714手，成交金额达4.54亿元。西藏药业属于生物制品行业，公司主要从事中成药、藏成药及化学药品的研发、生产和销售。2025年半年报显示，公司投资3亿元参股江苏晨泰医药，持股比例为13.04%。晨泰医药研发的佐利替尼是全球首款针对伴中枢神经系统转移的晚期非小细胞肺癌开展注册临床试验并取得显著成果的药物。8月22日主力资金净流出3891.59万元，近五个交易日累计净流出9780.61万元。风险提示：股市有风险，投资需谨慎。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","600211":"西藏药业","BK1161":"生物科技","BK1574":"生物医药B类股","BK0033":"西藏振兴","06978":"永泰生物-B","BK0239":"医药制造"},"translate_title":"Tibet Pharmaceutical's stock price fell 1.62%, and the layout of innovative drugs attracted attention","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"600211":1,"06978":1},"content_text":"西藏药业股价报46.04元，较前一交易日下跌1.62%。盘中最高触及46.70元，最低下探至45.69元，成交量为98714手，成交金额达4.54亿元。西藏药业属于生物制品行业，公司主要从事中成药、藏成药及化学药品的研发、生产和销售。2025年半年报显示，公司投资3亿元参股江苏晨泰医药，持股比例为13.04%。晨泰医药研发的佐利替尼是全球首款针对伴中枢神经系统转移的晚期非小细胞肺癌开展注册临床试验并取得显著成果的药物。8月22日主力资金净流出3891.59万元，近五个交易日累计净流出9780.61万元。风险提示：股市有风险，投资需谨慎。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2561540060","isCrawlerRequest":true}